Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16α[125I]iodo-17β-estradiol
- 1 April 1993
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 119 (4) , 207-214
- https://doi.org/10.1007/bf01624432
Abstract
Strategies for diagnosis and therapy in which sex steroid receptor ligands serve as carriers for radionuclides are attractive because a high incidence of carcinomas of the female genital tract and the breast that are seen clinically have an abundant expression of one or more of the receptor proteins. A radiohalogenated estrogen receptor (ER) ligand, 16α-[123I]iodo-17β-estradiol [123I]E, has met clinical criteria for receptor-mediated diagnostic imaging. Its [125]I-labeled sister nuclide derivative [125I]E decays by orbital electron capture with emission of very-low-energy (Auger) electrons, which gives this latter radiohalogen the potential to serve in pharmaceuticals for radiotherapy; as examples, [125I]deoxyuridine, when incorporated into the DNA molecule, or [125I]E, when bound to the receptor within ER-rich tumor cells, are both cytotoxic in vitro. Whereas the mechanisms and subcellular changes that accompany the cytotoxicity from [125I]deoxyuridine are well documented in the form of aberrations and breaks in the cellular DNA, the effects at the subcellular level causing the cytotoxicity of the sex steroid receptor ligand [125I]E have not been characterized and are the focus of our study. We found that in a standard colonyforming assay the addition of [125I]E to the cultures decreased the survival rate of ER-positive MCF-7 cells in a dose-dependent manner. The decreased survival rate was prevented by the addition of competing excess radioinert ER ligand (diethylstilbestrol); [125I]E did not reduce survival in ER-negative MCF-7 cells. The [125I]E-induced and ER-mediated cytotoxicity was accompanied by aberrations in the DNA components of the nuclei of the cells. These included chromatid and chromosome breaks, gaps, and tri-radial chromosome formation. Our findings add plausibility and credence to the notion that the cytotoxicity imparted by Auger-electron-emitting radioligands for sex steroid receptors is in part attributable to radiodecay that causes double-stranded breakage of DNA.Keywords
This publication has 37 references indexed in Scilit:
- Breast cancer imaging with radioiodinated oestradiolThe Lancet, 1990
- Binding of radiolabeled estrogens by human cells in vitro: Implications to the development of a new diagnostic and therapeutic modality in the treatment of malignancies with estrogen receptorsGynecologic Oncology, 1989
- Cytotoxicity of Receptor-Mediated 16 [125I]Iodo-estradiol in Cultured MCF-7 Human Breast Cancer CellsJNCI Journal of the National Cancer Institute, 1989
- Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol redThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Radiobiologic implications of the microscopic distribution of energy from radionuclidesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
- A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer cultureJournal of Steroid Biochemistry, 1984
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Estrogen receptor‐mediated cytotoxicity using iodine‐125Journal of Cellular Biochemistry, 1983
- Range of Radiochemical Damage to DNA with Decay of Iodine-125Science, 1981
- The Radiotoxicity of Iodine-125 in Mammalian Cells: II. A Comparative Study on Cell Survival and Cytogenetic Responses to 125 IUdR, 131 IUdR, and 3 HTdRRadiation Research, 1976